Next Science Financials
| NXSCF Stock | USD 0.06 0.02 28.75% |
Next |
Next Science Stock Summary
Next Science competes with Charlottes Web, and High Sierra. Next Science Limited, a medical technology company, researches, develops, and commercializes technologies that address the impacts of biofilms in human health in the United States and Australia. Next Science Limited was founded in 2012 and is headquartered in Chatswood, Australia. Next Science operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | The Zenith Building, |
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
| Benchmark | Dow Jones Industrial |
| Website | www.nextscience.com |
| Phone | 61 2 8607 5126 |
| Currency | USD - US Dollar |
Next Science Key Financial Ratios
There are many critical financial ratios that Next Science's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Next Science Limited reports annually and quarterly.| Return On Equity | -0.77 | |||
| Return On Asset | -0.39 | |||
| Beta | 0.64 | |||
| Z Score | 50.4 |
Next Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Next Science's current stock value. Our valuation model uses many indicators to compare Next Science value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Next Science competition to find correlations between indicators driving Next Science's intrinsic value. More Info.Next Science Limited is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Next Science's earnings, one of the primary drivers of an investment's value.Next Science Limited Systematic Risk
Next Science's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Next Science volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was sixty with a total number of output elements of one. The Beta measures systematic risk based on how returns on Next Science Limited correlated with the market. If Beta is less than 0 Next Science generally moves in the opposite direction as compared to the market. If Next Science Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Next Science Limited is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Next Science is generally in the same direction as the market. If Beta > 1 Next Science moves generally in the same direction as, but more than the movement of the benchmark.
Next Science December 26, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Next Science help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Next Science Limited. We use our internally-developed statistical techniques to arrive at the intrinsic value of Next Science Limited based on widely used predictive technical indicators. In general, we focus on analyzing Next Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Next Science's daily price indicators and compare them against related drivers.
| Downside Deviation | 28.54 | |||
| Information Ratio | 0.0189 | |||
| Maximum Drawdown | 112.38 | |||
| Value At Risk | (22.73) | |||
| Potential Upside | 1.75 |
Complementary Tools for Next Pink Sheet analysis
When running Next Science's price analysis, check to measure Next Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Next Science is operating at the current time. Most of Next Science's value examination focuses on studying past and present price action to predict the probability of Next Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Next Science's price. Additionally, you may evaluate how the addition of Next Science to your portfolios can decrease your overall portfolio volatility.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |